Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: A joint effort

Swiss Medical Weekly

Volumn 140, Issue 25-26, 2010, Pages 356-369

  Cathomas, Richard ^a   Helbling, Daniel ^b   Stenner, Frank ^c   Rothermundt, Christian ^d   Rentsch, Cyrill ^e   Shahin, Osama ^f   Seifert, Hans Helge ^c   Zaugg, Kathrin ^c   Lorch, Anja ^g   Mayer, Frank ^g   Beyer, Jörg ^h   De Santis, Maria ⁱ   Gillessen, Silke ^d  

^a KANTONSSPITAL GRAUBÜNDEN   (Switzerland)

^b OnkoZentrum Zürich   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f Kantonsspital Liestal   (Switzerland)

^g Department of Oncology ^*  (Germany)

^h VIVANTES KLINIKUM AM URBAN   (Germany)

ⁱ LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Follow up; Malignant germ cell tumour; Recommendations; Testicular cancer

Indexed keywords

ALPHA FETOPROTEIN; CARBOPLATIN; CHORIONIC GONADOTROPIN; FOLLITROPIN; LACTATE DEHYDROGENASE; LUTEINIZING HORMONE; TESTOSTERONE;

CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG SAFETY; ECHOGRAPHY; EVIDENCE BASED MEDICINE; FOLLOW UP; HUMAN; INTEGRATED HEALTH CARE SYSTEM; LIFESTYLE MODIFICATION; MALE; NON SEMINOMATOUS GERMINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; REVIEW; SEMINOMA; TESTIS CANCER;

EID: 77954134687     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Schmoll HJ, Souchon R, Krege S, Albers P, Beyer C, Kollmannsberger C et al. European Consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol. 2004;15:1377-99.
2. Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, et al. European Consensus Conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG). Part I and II. Eur Urol. 2008;53:478-96 and 497-513.
3. Carver BS, Shayegan B, Serio A, Motzer RJ, Bosl GJ, Sheinfeld J. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma. J Clin Oncol. 2007;25:1033-7. (Pubitemid 46596752)
4. Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, Horwich A, Laguna MP. Guidelines on testicular cancer. EAU European Association of Urology 2009.
5. Souchon R, Schmoll HJ, Krege S, Heidenreich A. Leitlinie zur Diagnostik und Therapie von Hodentumoren auf Grundlage evidenzbasierter Medizin: German Testicular Cancer Study Group, Zuckerschwendt Verlag 2002.
6. Testicular Cancer. NCCN National Comprehensive Cancer Network, version 2007. http://www.nccn.org/professionals/physician-gls/f-guidelines.asp.
7. Schmoll HJ, Jordan K, Huddart R, Laguna MP, Horwich A, Fizazi K, et al. Testicular seminoma: ESMO Clinical Recommendations for diagnosis, treatment and follow up. Ann Oncol. 2009;20(Suppl 4):ii83-88.
8. Schmoll HJ, Jordan K, Huddart R, Laguna MP, Horwich A, Fizazi K, et al. Testicular non-seminoma: ESMO Clinical Recommendations for diagnosis, treatment and follow. Ann Oncol. 2009;20(Suppl 4):ii89-96.
9. van As NJ, Gilbert DC, Money-Kyrle J, Bloomfield D, Beesley S, Dearnaley DP, et al. Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapse. Br J Cancer. 2008;98:1894-902. (Pubitemid 351821555)
10. Brenner DJ, Hall EJ. Computed tomography - an increasing source of radiation exposure. N Engl J Med. 2007;357:2277-84.
11. Brenner DJ, Elliston CD. Estimated radiation risks potentially associated with full-body CT screening. Radiology. 2004;232:735-8.
12. Nuver J, Smit AJ, Wolffenbuttel BHR, Sluiter WJ, Hoekstra HJ, Sleijfer DT, Gietema JA. The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer. J Clin Oncol. 2005;23:3718-25.
13. Haugnes HS, Aass N, Fossa SD, Dahl O, Klepp O, Wist EA, et al. Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors. J Cancer Surviv. 2008;2:128-37.
14. Van den Belt-Dusebout A, de Wit R, Gietema JA, Horenblas S, Louwman MWJ, Ribot JG, et al. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol. 2007;25:4370-8. (Pubitemid 350013842)
15. Fossa SD. Long-term sequelae after cancer therapy - survivorship after treatment for testicular cancer. Acta Oncol. 2004;43:134-41.
16. Travis LB, Fossa SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H et al. Second cancers among 40576 testicular cancer patients: Focus on long-term survivors. J Natl Cancer Inst. 2005;97:1354-65.
17. International Germ Cell Cancer Collaborative Group (IGCCCG). The International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancer. J Clin Oncol. 1997;15:594-603.
18. Venkitaraman R, Johnson B, Huddart RA, Parker CC, Horwich A, Dearnaley DP. The utility of lactate dehydrogenase in the follow-up of testicular germ cell tumours. BJU Int. 2007;100:30-2. (Pubitemid 46878559)
19. White PM, Howard GCW, Best JJK, Wright AR. The role of computed tomographic examination of the pelvis in the management of testicular germ cell tumors. Clin Radiol. 1997;52:124-9.
20. Harvey ML, Geldart TR, Duell R, Mead GM, Tung K. Routine computerised tomographic scans of the thorax in surveillance of stage I testicular non-seminomatous germ-cell cancer - a necessary risk? Ann Oncol. 2002;13:237-42.
21. Damgaard-Pedersen K, von der Maase H. Ultrasound and ultrasound guided biopsy, CT and lymphography in the diagnosis of retroperitoneal metastases in testicular cancer. Scand J Urol Nephrol Suppl. 1991;137:139-44.
22. Mezvrishvili Z, Tchanturaia Z, Toidze T, Turmanidze N, Kekelidze M, Managadze L. Is ultrasound of the retroperitoneum a valuable staging method in selecting testicular cancer patients for primary retroperitoneal lymph node dissection? Urol Int. 2007;78:226-9.
23. Dalal PU, Sohaib, SA, Huddart R. Imaging of testicular germ cell tumors. Cancer Imaging. 2006;6:124-34.
24. Warde P, Specht L, Horwich A, Oliver T, Panzarella T, Gospodarowicz M, von der Maase H. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol. 2002;20:4448-52. (Pubitemid 35334756)
25. Martin JM, Panzarella T, Zwahlen DR, Chung P, Warde P. Evidence-based guidelines for following stage 1 seminoma. Cancer. 2007;109:2248-56. (Pubitemid 46801554)
26. Mead GM, Fossa SD, Oliver RT, Fogarty J, Pollock P, Stenning SP. Relapse patterns in 2466 stage I seminoma patients entered into Medical Research Council randomised trials. J Clin Oncol. 2008;26(suppl):abstract 5020.
27. TRISST (MRC TE24) Trial of imaging and schedule in seminoma testis. http://www.ctu.mrc.ac.uk/studies/TE24.asp.
28. Hoskin P, Dilly S, Easton D, Horwich A, Hendry W, Peckham MJ. Prognostic factors in stage I non-seminomatous germ cell testicular tumors managed by orchiectomy and surveillance: implications for adjuvant therapy. J Clin Oncol. 1986;4:1031-6. (Pubitemid 16059729)
29. Albers P, Siener R, Kliesch S, Weissbach L, Krege S, Sparwasser C, et al. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial. J Clin Oncol. 2003;21:1505-12.
30. Cullen MH, Stenning SP, Parkinson MC, Fossa SD, Kaye SB, Horwich AH, et al. Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: A Medical Research Council report. J Clin Oncol. 1996;14:1106-13.
31. Rustin GJ, Mead GM, Stenning SP, Vasey PA, Aass N, Huddart RA, et al. Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197 - The National Cancer Research Institute Testis Cancer Clinical Studies Group. J Clin Oncol. 2007;25:1310-5.
32. Kondagunta GV, Motzer RJ. Chemotherapy for advanced germ cell tumors. J Clin Oncol. 2006;24:5493-502.
33. Carver BS, Bianco FJ Jr, Shayegan B, Vickers A, Motzer RJ, Bosl GJ, Sheinfeld J. Predicting teratoma in the retroperitoneum in men undergoing postchemotherapy retroperitoneal lymph node dissection. J Urol. 2006;176:100-3.
34. Carver BS, Shayegan B, Eggener S, Stasi J, Motzer RJ, Bosl GJ, Sheinfeld J. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection. J Clin Oncol. 2007;25:4365-9.